- ￥538 - 13600
- TargetMol
- 美国
- T22360
- 2025年07月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
零下80~20°C
- 保质期：
Powder: -20°C for 3 years In solvent: -80°C for 2 years
- 英文名：
MDR-652
- 库存：
10
- 供应商：
TargetMol
- CAS号：
1933528-96-1
- 规格：
5 mg/1 mg/2 mg/500 mg/50 mg/1 mL/100 mg/25 mg/10 mg
| 规格： | 5 mg | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥538.0 |
| 规格： | 2 mg | 产品价格： | ￥789.0 |
| 规格： | 500 mg | 产品价格： | ￥13600.0 |
| 规格： | 50 mg | 产品价格： | ￥4790.0 |
| 规格： | 1 mL | 产品价格： | ￥1450.0 |
| 规格： | 100 mg | 产品价格： | ￥6780.0 |
| 规格： | 25 mg | 产品价格： | ￥3370.0 |
| 规格： | 10 mg | 产品价格： | ￥1990.0 |
Product Introduction
Bioactivity
英文名:MDR-652
描述:MDR-652 is a highly specific and efficacious agonist of nonpungent transient receptor potential vanilloid 1 (TRPV1) with Ki value of 11.4 nM and 23.8 nM for hTRPV1 and rTRPV1 respectively and EC50s for hTRPV1 and rTRPV1 are 5.05 and 93 nM respectively. MDR-652 is a potent topical analgesic.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Use of Ribozymes to Specifically Alter the MDR-1 Phenotype
(1 ). Multidrug resistance (MDR) is one of the best characterized phenomena that is associated with cross-resistance to structurally unrelated lipophilic drugs, including a wide variety of natural products and synthetic drugs, such as anthracyclines, vinca
Anti-MDR1 Ribozyme Gene Therapy
Multidrug resistance (MDR) in human cancer seriously limits the efficacy of anticancer agents. Circumvention of MDR is, thus, one of the urgent goals for successful cancer chemotherapy.
Detection of the MDR1 P-Glycoprotein Expression and Function
by the MDR1 gene and expressed on the membrane of tumor and normal cells. Sensitive and reproducible detection of Pgp expression and function are critical for the development of new MDR1 drugs and clinical protocols aimed at modulating Pgp-mediated multidrug
技术资料暂无技术资料 索取技术资料
